TFS Capital’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,540
Closed -$276K 464
2017
Q2
$276K Buy
+3,540
New +$266K 0.11% 367
2017
Q1
Sell
-16,991
Closed -$1.34M 926
2016
Q4
$1.34M Sell
16,991
-3,372
-17% -$262K 0.36% 79
2016
Q3
$1.59M Sell
20,363
-5,021
-20% -$364K 0.38% 74
2016
Q2
$1.75M Sell
25,384
-4,222
-14% -$291K 0.32% 38
2016
Q1
$2.11M Sell
29,606
-15,213
-34% -$955K 0.3% 49
2015
Q4
$2.79M Buy
+44,819
New +$2.73M 0.3% 99
2015
Q2
Sell
-16,956
Closed -$805K 1160
2015
Q1
$805K Sell
16,956
-26,452
-61% -$1.17M 0.08% 415
2014
Q4
$1.88M Buy
43,408
+24,400
+128% +$997K 0.18% 157
2014
Q3
$653K Sell
19,008
-41,991
-69% -$1.48M 0.06% 514
2014
Q2
$2.23M Buy
60,999
+14,641
+32% +$497K 0.18% 160
2014
Q1
$1.56M Sell
46,358
-12,800
-22% -$422K 0.1% 295
2013
Q4
$2.01M Buy
59,158
+19,631
+50% +$680K 0.09% 311
2013
Q3
$1.26M Sell
39,527
-2,712
-6% -$72.1K 0.06% 501
2013
Q2
$954K Buy
+42,239
New +$914K 0.04% 618

Other funds holding CMD

TFS Capital's CMD Position: Q3 2017 in Review

TFS Capital sold out of Cantel Medical Corporation (CMD) in Q3 2017, closing a stake of 3,540 shares — an estimated $276K sold.

TFS Capital first reported a position in CMD in Q2 2013 and held it in 14 quarters. The position peaked at $2.79M in Q4 2015. 231 funds tracked by Wall St. Rank hold CMD as of Q3 2017.

  • TFS Capital reported no remaining Cantel Medical Corporation position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 3,540 Cantel Medical Corporation shares in Q3 2017, an estimated $276K.
  • TFS Capital first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 14 quarters.
  • TFS Capital's Cantel Medical Corporation position peaked at $2.79M in Q4 2015.
  • 231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.